EH
EHC.US Encompass Health Corp
- Market cap
- USD 13.8B
- P/E
- 22.6x
- P/B
- 5.16x
- ROE
- 24.8%
- Dividend yield
- 0.51%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is EHC.US undervalued?
Graham numberEHC.US trades 127.4% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Encompass Health Corp fundamental analysis
No fundamental analysis for Encompass Health Corp yet.
Encompass Health Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Encompass Health Corp
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such…
Full company profileEncompass Health Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Encompass Health Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 3.64B | 3.91B | 4.28B | 4.61B | 3.57B | 4.01B | 4.35B | 4.80B | 5.37B | 5.94B | 6.39B |
| Gross Profit | 3.50B | 3.76B | 4.12B | 4.44B | 3.40B | 1.70B | 1.75B | 1.98B | 2.23B | 2.56B | 2.35B |
| Operating Income | 649M | 649M | 682M | 693M | 662M | 659M | 630M | 732M | 865M | 1.05B | 1.17B |
| EBITDA | 827M | 835M | 840M | 941M | 740M | 889M | 870M | 1.02B | 1.19B | 1.40B | 1.57B |
| Net Income | 248M | 271M | 292M | 359M | 284M | 412M | 271M | 352M | 456M | 566M | 664M |
| EPS | 2.49 | 2.73 | 2.93 | 3.61 | 2.85 | 4.11 | 2.70 | 3.47 | 4.46 | 5.54 | 6.66 |
| Balance Sheet | |||||||||||
| Total Assets | 4.68B | 4.89B | 5.23B | 6.08B | 6.45B | 6.86B | 5.64B | 6.10B | 6.53B | 7.09B | 7.57B |
| Total Liabilities | 3.61B | 3.25B | 3.36B | 4.15B | 4.44B | 4.47B | 3.77B | 3.81B | 3.69B | 3.81B | 4.01B |
| Shareholders' Equity | 736M | 1.18B | 1.33B | 1.35B | 1.59B | 1.91B | 1.31B | 1.65B | 2.07B | 2.44B | 2.68B |
| Cash & Short-term Investments | 40.5M | 54.4M | 69.2M | 94.8M | 224M | 49.4M | 21.8M | 142M | 85.4M | 145M | 76.2M |
| Total Debt | 3.02B | 2.58B | 2.51B | 3.35B | 3.54B | 3.48B | 2.99B | 2.93B | 2.71B | 2.71B | 2.80B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 606M | 657M | 762M | 635M | 705M | 716M | 706M | 851M | 1.00B | 1.18B | 1.28B |
| Capital Expenditure | 203M | 245M | 271M | 404M | 408M | 551M | 584M | 583M | 643M | 736M | 823M |
| Free Cash Flow | 403M | 412M | 492M | 231M | 297M | 165M | 122M | 268M | 360M | 439M | 454M |
| Ratios | |||||||||||
| ROE | 33.6% | 22.9% | 22.0% | 26.5% | 17.9% | 21.6% | 20.7% | 21.4% | 22.0% | 23.2% | 24.8% |
| ROA | 5.3% | 5.5% | 5.6% | 5.9% | 4.4% | 6.0% | 4.8% | 5.8% | 7.0% | 8.0% | 8.8% |
| Net Profit Margin | 6.8% | 6.9% | 6.8% | 7.8% | 8.0% | 10.3% | 6.2% | 7.3% | 8.5% | 9.5% | 10.4% |
| Debt to Equity | 4.10x | 2.18x | 1.89x | 2.48x | 2.23x | 1.82x | 2.28x | 1.78x | 1.31x | 1.11x | 1.05x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Encompass Health Corp dividends
- Dividend yield
- 0.51%
- Forward dividend
- 0.84 USD
- Payout ratio
- 12.6%
- Ex-dividend date
- Jan 4, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 71.1M | 0.70 | 12.6% |
| 2024 | USD 62.8M | 0.61 | 13.8% |
| 2023 | USD 60.4M | 0.60 | 17.2% |
| 2022 | USD 99.0M | 0.99 | 36.5% |
| 2021 | USD 112M | 1.12 | 27.3% |
| 2020 | USD 112M | 1.12 | 39.4% |
| 2019 | USD 109M | 1.09 | 30.3% |
| 2018 | USD 101M | 1.01 | 34.5% |
| 2017 | USD 91.5M | 0.92 | 33.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1257:1000 on Jul 1, 2022.
Who owns Encompass Health Corp
- Insiders 1.02%
- Institutions 98.98%
- Public & others 0.00%
- Shares outstanding 98.1M
- Free float 97.1M
Top funds holding EHC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 3.55M | 3.61% | +0.05% | Oct 2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 3.12M | 3.18% | -1.23% | Sep 2026 |
| FullerThaler Behavioral Sm-Cp Eq R6 | 2.35M | 2.39% | +10.51% | Jun 2026 |
| Vanguard Small Cap Index | 2.22M | 2.26% | -2.68% | Sep 2026 |
| Vanguard MStar Small Cap Value Index | 1.45M | 1.47% | -0.30% | Sep 2026 |
| T. Rowe Price US Large-Cap Core | 1.16M | 1.18% | 0.00% | Sep 2026 |
| Vanguard Explorer Inv | 1.06M | 1.08% | +2.09% | Sep 2026 |
| American Funds SMALLCAP World A | 963K | 0.98% | +13.54% | Sep 2026 |
| JHancock Disciplined Value Mid Cap I | 870K | 0.89% | -1.67% | Aug 2026 |
| State Street® SPDR® S&P MIDCAP 400® ETF | 729K | 0.74% | +0.55% | Sep 2026 |
| Allspring Special Mid Cap Value Inst | 649K | 0.66% | 0.00% | Sep 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 593K | 0.60% | -0.26% | Oct 2026 |
| State Street SPDR Port S&P 400 Md CpETF | 536K | 0.55% | +0.05% | Oct 2026 |
| Carillon Scout Mid Cap I | 519K | 0.53% | +57.40% | Sep 2026 |
| American Century Small Cap Growth Inv | 516K | 0.53% | -1.22% | Sep 2026 |
| Fidelity Extended Market Index | 453K | 0.46% | -6.49% | Sep 2026 |
| T. Rowe Price Integrated US Sm Gr Eq | 450K | 0.46% | +6.93% | Sep 2026 |
| iShares Russell Mid-Cap ETF | 418K | 0.43% | -0.06% | Oct 2026 |
| Thrivent Small Cap Stock A | 384K | 0.39% | -0.04% | Sep 2026 |
| Fidelity Mid Cap Index | 379K | 0.39% | +1.35% | Sep 2026 |
Top institutions holding EHC.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| BlackRock Inc | 10.5M | 10.68% | -2.64% | Jun 2026 |
| T. Rowe Price Associates, Inc. | 5.06M | 5.15% | +9.90% | Jun 2026 |
| Vanguard Portfolio Management, LLC | 4.92M | 5.02% | -0.70% | Jun 2026 |
| Vanguard Capital Management, LLC | 4.48M | 4.56% | +0.22% | Jun 2026 |
| Wellington Management Company LLP | 3.28M | 3.34% | -14.81% | Jun 2026 |
| State Street Corp | 3.19M | 3.25% | +1.30% | Jun 2026 |
| Citadel Advisors Llc | 2.56M | 2.61% | +400.72% | Jun 2026 |
| AllianceBernstein L.P. | 2.47M | 2.52% | -5.70% | Jun 2026 |
| Fuller & Thaler Asset Management Inc | 2.46M | 2.51% | +10.34% | Jun 2026 |
| Two Sigma Investments LLC | 2.27M | 2.31% | +2.05% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 1.92M | 1.96% | +10.28% | Sep 2026 |
| Geode Capital Management, LLC | 1.89M | 1.93% | -0.42% | Jun 2026 |
| The Goldman Sachs Group Inc | 1.55M | 1.58% | -14.12% | Jun 2026 |
| Amvescap Plc. | 1.16M | 1.18% | -65.71% | Jun 2026 |
| Arrowstreet Capital Limited Partnership | 1.16M | 1.18% | -2.17% | Jun 2026 |
| NORGES BANK | 1.15M | 1.18% | -7.99% | Jun 2026 |
| William Blair Investment Management, LLC | 1.15M | 1.17% | +43.32% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 1.15M | 1.17% | +27.86% | Jun 2026 |
| JPMorgan Chase & Co | 1.13M | 1.16% | -7.95% | Jun 2026 |
| American Century Companies Inc | 1.05M | 1.07% | +39.68% | Jun 2026 |
Encompass Health Corp company profile
- Company name
- Encompass Health Corp
- Ticker
- EHC.US
- Exchange
- USA Stocks
- Listed since
- Sep 30, 1986
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 29,875
- Fiscal year end
- December
- Address
- 9001 Liberty Parkway, Birmingham, AL, United States, 35242
- Phone
- 205 967 7116
- Website
- encompasshealth.com
About Encompass Health Corp
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
Encompass Health Corp management
10- Mr. Mark J. TarrCEO, President & Director · born 1962
- Mr. Douglas E. ColtharpExecutive VP & CFO · born 1962
- Mr. Patrick W. TuerExecutive VP & COO · born 1985
- Mr. John Patrick DarbyExecutive VP, General Counsel & Corporate Secretary · born 1965
- Dr. Elissa Joy Charbonneau D.O., M.S.Chief Medical Officer · born 1960
- Mr. Andrew L. PriceSenior VP & Chief Accounting Officer · born 1967
- Mr. Rusty YeagerChief Information Officer & Senior VP
- Mr. Mark MillerSenior Vice President of Investor Relations & Strategic Planning
- Ms. Dawn RockChief Compliance Officer
- Mr. Anthony A. HernandezChief Human Resources Officer · born 1966